合成生物学的关键技术及应用

doi:10.13560/j.cnki.biotech.bull.1985.2017.01.002

摘要/Abstract

摘要： 合成生物学是以工程化设计思路，构建标准化的元器件和模块，改造已存在的天然系统或者从头合成全新的人工生命体系。人们利用基因重组技术和基因定位编辑来实现对生命系统的特殊编程并执行特殊的功能;模块化处理代谢途径，优化元器件间的组合搭配，以最优的模式来实现化学品的合成。目前合成生物学已在能源、化工、医药等行业取得了重大进展，合成生物学将给人们的生活带来重大改变也将继续是科学家们研究和关注的热点。就目前合成生物学涉及的基因组编辑和模块化表达等关键技术及应用进行综述。

关键词: 合成生物学, 基因重组, 基因组编辑, 模块化

Abstract: Synthetic biology is to reconstruct the existing natural system by building standardized components and modules and synthesize new artificial life system from scratch under the guidance of engineering design ideas.With the help of gene recombination technology and genome editing technology,we can program life system to comply special functions. After realizing modular analysis of metabolic pathways and optimizing the combination between the components we can synthesize chemicals with excellent patterns. At present,people have made great progress in the fields of energy,chemical industry and medicine. Synthetic biology will bring great changes to people’s life and will continue to be the hotspot of research.The review describes the major applications and the key technologies of synthetic biology in genome editing and modular representation.

Key words: synthetic biology, gene recombination, genome editing, modularization

杨菊，邓禹. 合成生物学的关键技术及应用[J]. 生物技术通报, 2017, 33(1): 12-23.

YANG Ju, DENG Yu. Key Technologies and Applications of Synthetic Biology[J]. Biotechnology Bulletin, 2017, 33(1): 12-23.

参考文献

[1] Jackson D, Symons RH, Berg P, et al. Biochemical method for inserting new genetic information into DNA of Simian Virus 40：circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli[J]. Proceedings of the National Academy of Sciences of the United States of America, 1972, 69（10）：2904-2909.
[2] Cohen SN, Chang AC, Boyer HW, et al. Construction of biologically functional bacterial plasmids in vitro[J]. Proceedings of the National Academy of Sciences of the United States of America, 1973, 70（11）：3240-3244.
[3] Fuchs C, Rosenvold EC, Honigman A, et al. A simple method for identifying the palindromic sequences recognized by restriction endonucleases：the nucleotide sequence of the AvaII site[J]. Gene, 1978, 4（1）：1-23.
[4] Hobom B. Gene surgery：on the threshold of synthetic biology[J]. Med Klin, 1980, 75（24）：834-841.
[5] Gibson DG, Young L, Chuang RY, et al. Enzymatic assembly of DNA molecules up to several hundred kilobases[J]. Nature Methods, 2009, 6（5）：343-345.
[6] Shetty RP, Endy D, Knight TF. Engineering BioBrick vectors from BioBrick parts[J]. Journal of Biological Engineering, 2008, 2（1）：5.
[7] Knight T. Idempotent vector design for standard assembly of biobricks[J]. MIT Artificial Intelligence Laboratory;MIT Synthetic Biology Working Group, 2003.
[8] Moon TS, Yoon S, Lanza AM, et al. Production of glucaric acid from a synthetic pathway in recombinant Escherichia coli[J]. Applied and Environmental Microbiology, 2009, 75（3）：589-595.
[9] Yim H, Haselbeck R, Niu W, et al. Metabolic engineering of Escherichia coli for direct production of 1, 4-butanediol[J]. Nature Chemical Biology, 2011, 7（7）：445-452.
[10] Martin CH, Dhamankar H, Tseng HC, et al. A platform pathway for production of 3-hydroxyacids provides a biosynthetic route to 3-hydroxy-y-butyrolactone[J]. Nature Communications, 2013, 4：1414.
[11] Paddon CJ, Keasling JD. Semi-synthetic artemisinin：a model for the use of synthetic biology in pharmaceutical development[J]. Nature Reviews Microbiology, 2014, 12（5）：355-367.
[12] Paddon CJ, Westfall PJ, Pitera DJ, et al. High-level semi-synthetic production of the potent antimalarial artemisinin[J]. Nature, 2013, 496（7446）：528-532.
[13] Cho A, Yun H, Park JH, et al. Prediction of novel synthetic pathways for the production of desired chemicals[J]. BMC Systems Biology, 2010, 4：35.
[14] Zhang F, Carothers JM, Keasling JD. Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids[J]. Nature Biotechnology, 2012, 30（4）：354-359.
[15] 谢科, 饶力群, 李红伟, 等. 基因组编辑技术在植物中的研究进展与应用前景[J]. 中国生物工程杂志, 2013, 33（6）：99-104.
[16] Kim SC, Skowron PM, Szybalski W, et al. Structural requirements forFokI-DNA interaction and oligodeoxyribonucleoti 319de-instructed cleavage[J]. Journal of Molecular Biology, 1996, 258（4）：638-649.
[17] 程曦, 王文义, 邱金龙. 基因组编辑：植物生物技术的机遇与挑战[J]. 生物技术通报, 2015, 31（4）：25-33.
[18] Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes：zinc finger fusions to Fok I cleavage domain[J]. Proc Natl Acad Sci USA, 1996, 93（3）：1156-1160.
[19] Smith J, Bibikova M, Whitby FG, et al. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains[J]. Nucleic Acids Res, 2000, 28（17）：3361-3369.
[20] Bibikova M, Carroll D, Segal DJ, et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases[J]. Mol Cell Biol, 2001, 21（1）：289-297.
[21] Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors[J]. Science, 2009, 326（5959）：1501.
[22] Garneau JE, Dupuis M, Villion M, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA[J]. Nature, 2010, 468（7320）：67-71.
[23] Jansen R, Embden JD, Gaastra W, et al. Identification of genes that are associated with DNA repeats in prokaryotes[J]. Mol Microbiol, 2002, 43（6）：1565-1575.
[24] Bhaya D, Davison M, Barrangou R. CRISPR-Cas systems in bacteria and archaea：versatile small RNAs for adaptive defense and regulation[J]. Annual Review of Genetics, 2011, 45：273297.
[25] Gasiunas G, Siksnys V. RNA-dependent DNA endonuclease Cas9 of the CRISPR system：Holy Grail of genome editing?[J]. Trends in Microbiology, 2013, 21（11）：562-567.
[26] Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNAguided DNA endonuclease in adaptive bacterial immunity[J]. Science, 2012, 337（6096）：816-821.
[27] Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nature Protocols, 2013, 8（11）：2281-2308.
[28] Jiang W, Bikard D, Cox D, et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems[J]. Nature Biotechnology, 2013, 31（3）：233-239.
[29] Yu Z, Ren M, Wang Z, et al. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila[J]. Genetics, 2013, 195（1）：289-291.
[30] Gilbert LA, Larson MH, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes[J]. Cell, 2013, 154（2）：442-451.
[31] Isaacs FJ, Carr PA, Wang HH, et al. Precise manipulation of chromosomes in vivo enables genome-wide codon replacement[J]. Science, 2011, 333（6040）：348-353.
[32] Wang HH, Isaacs FJ, Carr PA, et al. Programming cells by multiplex genome engineering and accelerated evolution[J]. Nature, 2009, 460（7257）：894-898.
[33] Quintin MJ, Ma NJ, Ahmed S, et al. Merlin：Computer-aided oligonucleotide design for large scale genome engineering with MAGE[J]. Acs Synthetic Biology, 2016, 5（6）：452-458.
[34] Zhang YH, Evans BR, Mielenz JR, et al. High-yield hydrogen production from starch and water by a synthetic enzymatic pathway[J]. PLos One, 2007, 2（5）：1-6.
[35] Sonderegger M, Schümperli M, Sauer U. Metabolic engineering of a phosphoketolase pathway for pentose catabolism in Saccharomyces cerevisiae[J]. Appl Environ Microbiol, 2004, 70（5）：2892-2897.
[36] Trinh CT, Unrean P, Srienc F. Minimal Escherichia coli cell for the most efficient production of ethanol from hexoses and pentoses[J]. Appl Environ Microbiol, 2008, 74（12）：3634-3643.
[37] Hanai T, Atsumi S, Liao JC. Engineered synthetic pathway for isopropanol production in Escherichia coli[J]. Appl Environ Microbiol, 2007, 73（24）：7814-7818.
[38] Atsumi S, Cann AF, Connor MR, et al. Metabolic engineering of Escherichia coli for 1-butanol production[J]. Metab Eng, 2008, 10（6）：305-311.
[39] Steen EJ, Kang Y, Bokinsky G, et al. Microbial production of fatty-acid-derived fuels and chemicals from plant biomass[J]. Nature, 2010, 463（7280）：559-562.
[40] Peralta-Yahya PP, Ouellet M, Chan R, et al. Identification and microbial production of a terpene-based advanced biofuel[J]. Nat Commun, 2011, 2：483.
[41] Deng Y, Fong SS. Metabolic engineering of Thermobifida fusca for direct aerobic bioconversion of untreated lignocellulosic biomass to 1-propanol[J]. Metabolic Engineering, 2011, 13（5）：570-577.
[42] Van Duuren J, Brehmer B, Mars AE, et al. A limited LCA of bio-adipic acid：Manufacturing the nylon‐6, 6 precursor adipic acid using the benzoic acid degradation pathway from different feedstocks[J]. Biotechnology and Bioengineering, 2011, 108（6）：1298-1306.
[43] Sato K, Aoki M, Noyori R. A” green” route to adipic acid：Direct oxidation of cyclohexenes with 30 percent hydrogen peroxide[J]. Science, 1998, 281（5383）：1646-1647.
[44] Picataggio S, Beardslee T. Biological methods for preparing adipic acid：U. S. Patent 8, 241, 879[P]. 2012-8-14.
[45] Noack H, Georgiev V, Blomberg MRA, et al. Theoretical insights into heme-catalyzed oxidation of cyclohexane to adipic acid[J]. Inorganic Chemistry, 2011, 50（4）：1194-1202.
[46] Li X, Wu D, Lu T, et al. Highly efficient chemical process to convert mucic acid into adipic acid and DFT studies of the mechanism of the rhenium-catalyzed deoxydehydration[J]. Angewandte Chemie International Edition, 2014, 53（16）：4200-4204.
[47] Niu W, Draths KM, Frost JW. Benzene-free synthesis of adipic acid[J]. Biotechnology Progress, 2002, 18（2）：201-211.
[48] Jung YK, Kim TY, Park SJ, et al. Metabolic engineering of Escheri- chia coli for the production of polylactic acid and its copolymers [J]. Biotechnol Bioeng, 2010, 105（1）：161-171.
[49] Yang TH, Kim TW, Kang HO, et al. Biosynthesis of polylactic acid and its copolymers using evolved propionate CoA transferase and PHA synthase[J]. Biotechnol Bioeng, 2010, 105（1）：150-160.
[50] Celińska E. Debottlenecking the 1, 3-propanediol pathway by metabolic engineering[J]. Biotechnol Adv, 2010, 28（4）：519-530.
[51] Deng Y, Mao Y, Zhang XJ. Metabolic engineering of a laboratory-evolved Thermobifida fusca muC strain for malic acid production on cellulose and minimal treated lignocellulosic biomass[J]. Biotechnology Progress, 2016, 32（1）：14-20.
[52] Ro DK, Paradise EM, Ouellet M, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast[J]. Nature, 2006, 440（7086）：940-943.
[53] Hale V, Keasling JD, Renninger N, et al. Microbially derived artemisinin：A biotechnology solution to the global problem of access to affordable antimalarial drugs[J]. Am J Trop Med Hyg, 2007, 77：198-202.
[54] Engels B, Dahm P, Jennewein S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol（Paclitaxel）production[J]. Metab Eng, 2008, 10（3-4）：201-206.
[55] Galanie S, Thodey K, Trenchard IJ, et al. Complete biosynthesis of opioids in yeast[J]. Science, 2015, 349：1095-1100 .
[56] Thodey K, Galanie S, Smolke CD. A microbial biomanufacturing platform for natural and semisynthetic opioids[J]. Nat Chem Biol, 2014, 10：837-844.
[57] Anderson JC, Clarke EJ, Arkin AP, et al. Environmentally controlled invasion of cancer cells by engineered bacteria[J]. Journal of Molecular Biology, 2006, 355（4）：619-627.
[58] Weber W, Schoenmakers R, Keller B, et al. A synthetic mammalian gene circuit reveals antituberculosis compounds[J]. Proceedings of the National Academy of Sciences, 2008, 105（29）：9994-9998.
[59] Kemmer C, Gitzinger M, Daoud-El Baba M, et al. Self-sufficient control of urate homeostasis in mice by a synthetic circuit[J]. Nature Biotechnology, 2010, 28（4）：355-360.
[60] De Las Heras A, Carreño CA, De Lorenzo V. Stable implantation of orthogonal sensor circuits in Gram-negative bacteria for environmental release[J]. Environmental Microbiology, 2008, 10（12）：3305-3316.